Advertisement

The Importance of Controlling Body Weight After a Diagnosis of Breast Cancer: The Role of Diet and Exercise in Breast Cancer Patient Management

  • Michelle Harvie
Chapter

Abstract

Overweight and obesity occur in approximately 60% of patients at diagnosis of breast cancer and a further 60–75% gain weight during treatment, including those who were previously of a healthy weight. Excess adiposity is linked to increased mortality from breast cancer and from weight-related co-morbidities (e.g. CV disease and other cancers) and is a major psychological concern to patients. Data from recent randomised controlled trials suggest that weight control can reduce breast cancer recurrence by 24%. Weight control is not a routine part of breast cancer management for the majority of patients. Successful interventions are likely to require a combined diet and exercise approach and behaviour change counselling. Current evidence suggests that weight control has the potential to improve outcome and wellbeing for breast cancer patients, although the optimum timing, composition of the diet and delivery of interventions are important considerations for future research.

Keywords

Breast Cancer Breast Cancer Patient Aromatase Inhibitor Weight Control Adjuvant Endocrine Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    IARC (International Agency of Cancer Research). (2009) http://www-dep.iarc.fr/. Accessed 21-1-0009.
  2. 2.
    Bray F, McCarron P, Parkin DM. (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6:229–239.CrossRefPubMedGoogle Scholar
  3. 3.
    Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA. (2007) Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst 99:1335–1339.CrossRefPubMedGoogle Scholar
  4. 4.
    Cancer Research UK. (2009) UK cancer mortality statistics. http://info.cancerresearchuk.org/cancerstats/types/breast/mortality/; Accessed 21-1-2009.
  5. 5.
    Surveillance Epidemiology and End Results (SEER) Breast Cancer Statistics. (2009) http://seer.cancer.gov/faststats/selections.php#Output. Accessed 21-1-2009.
  6. 6.
    Fentiman IS, Fourquet A, Hortobagyi GN. (2006) Male breast cancer. Lancet 367:595–604.CrossRefPubMedGoogle Scholar
  7. 7.
    Department of Health Statistics on Obesity Physical Activity and Diet: England. (2008) http://www.ic.nhs.uk/webfiles/publications/opan08/OPAD%20Jan%202008%20final%20v7%20with%20links%20and%20buttons%20-%20NS%20logo%20removed%2020112008.pdf. Accessed 13-11–2008.
  8. 8.
    Dunn SE, Kari FW, French J, et al. (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667–4672.PubMedGoogle Scholar
  9. 9.
    ATAC Trialists’ Group. (2009) Personal Communication.Google Scholar
  10. 10.
    Caan BJ, Emond JA, Natarajan L, et al. (2006) Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat 99:47–57.CrossRefPubMedGoogle Scholar
  11. 11.
    Goodwin PJ, Panzarella T, Boyd NF. (1988) Weight gain in women with localized breast cancer – a descriptive study. Breast Cancer Res Treat 11:59–66.CrossRefPubMedGoogle Scholar
  12. 12.
    Harvie MN, Campbell IT, Baildam A, Howell A. (2004) Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 83:201–210.CrossRefPubMedGoogle Scholar
  13. 13.
    Saquib N, Flatt SW, Natarajan L, et al. (2007) Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study. Breast Cancer Res Treat 105:177–186.CrossRefPubMedGoogle Scholar
  14. 14.
    Heideman WH, Russell NS, Gundy C, Rookus MA, Voskuil DW. (2009) The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors. Eur J Cancer 45:119–126.CrossRefPubMedGoogle Scholar
  15. 15.
    Han HS, Lee KW, Kim JH. et al. (2009) Weight changes after adjuvant treatment in Korean women with early breast cancer. Breast Cancer Res Treat 114:147–153CrossRefPubMedGoogle Scholar
  16. 16.
    Harvie M, Howell A. (2006) Incorporating weight control into the management of patients with early breast cancer in the UK. In: Mctiernan A (ed) Cancer Prevention and Management Through Exercise and Weight Control. Marcel Dekker Inc., New York.Google Scholar
  17. 17.
    Malinovszky KM, Cameron D, Douglas S, et al. (2004) Breast cancer patients’ experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET). Breast 13:363–368.CrossRefPubMedGoogle Scholar
  18. 18.
    Baum M, Budzar AU, Cuzick J, et al. (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first Results of the ATAC randomised trial. Lancet 359:2131–2139.CrossRefPubMedGoogle Scholar
  19. 19.
    Espeland MA, Stefanick ML, Kritz-Silverstein D, et al. (1997) Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metabol 82:1549–1556.CrossRefGoogle Scholar
  20. 20.
    Dawson-Hughes B, Harris S. (1992) Regional changes in body composition by time of year in healthy postmenopausal women. Am J Clin Nutr 56:307–313.PubMedGoogle Scholar
  21. 21.
    Larosche I, Letteron P, Fromenty B, et al. (2007) Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver. J Pharmacol Exp Ther 321:526–535.CrossRefPubMedGoogle Scholar
  22. 22.
    Machinal-Quelin F, Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. (2002) Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine 18:179–184.CrossRefPubMedGoogle Scholar
  23. 23.
    Francini G, Petrioli R, Montagnani A, et al. (2006) Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids. Br J Cancer 95:153–158.CrossRefPubMedGoogle Scholar
  24. 24.
    Harvie MN, Howell A, Thatcher N, Baildam A, Campbell I. (2005) Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy – a longitudinal study. Br J Cancer 92:673–680.CrossRefPubMedGoogle Scholar
  25. 25.
    Carmichael AR, Bendall S, Lockerbie L, Prescott RJ, Bates T. (2004) Does obesity compromise survival in women with breast cancer? Breast 13:93–96.CrossRefPubMedGoogle Scholar
  26. 26.
    Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DS. (2008) Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst 100:1724–1733.CrossRefPubMedGoogle Scholar
  27. 27.
    Daniell HW. (2009) Weight loss after breast cancer diagnosis may not improve prognosis. J Clin Oncol 27:829–830.CrossRefPubMedGoogle Scholar
  28. 28.
    Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. (1990) Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8:1327–1334.PubMedGoogle Scholar
  29. 29.
    Kroenke CH, Chen WY, Rosner B, Holmes MD. (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23:1370–1378.CrossRefPubMedGoogle Scholar
  30. 30.
    Hede K. (2008) Fat may fuel breast cancer growth. J Natl Cancer Inst 100:298–299.CrossRefPubMedGoogle Scholar
  31. 31.
    Chlebowski RT, Blackburn GL, Thomson CA, et al. (2006) Dietary fat reduction and breast cancer outcome: interim efficacy Results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst 98:1767–1776.CrossRefPubMedGoogle Scholar
  32. 32.
    McTiernan A, Rajan KB, Tworoger SS, et al. (2003) Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21:1961–1966.CrossRefPubMedGoogle Scholar
  33. 33.
    Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP. (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467–1476.PubMedGoogle Scholar
  34. 34.
    Berclaz G, Li S, Price KN, et al. (2004) Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 15:875–884.CrossRefPubMedGoogle Scholar
  35. 35.
    Lethaby AE, Mason BH, Harvey VJ, Holdaway IM. (1996) Survival of women with node negative breast cancer in the Auckland region. NZ Med J 109:330–333.Google Scholar
  36. 36.
    Lee CW, Norris B, Moravan V, Olivotto IA. (2003) Does body mass index influence the effectiveness of adjuvant tamoxifen in post menopausal women with early stage breast cancer? Breast Cancer Res Treat 82(Suppl 1):(Abstr 309).Google Scholar
  37. 37.
    Lippman ME, Krueger KA, Eckert S, et al. (2001) Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. J Clin Oncol 19:3111–3116.PubMedGoogle Scholar
  38. 38.
    Fukuda M, Watanabe H, Suda T, Shimizu S. (1999) Sequential changes in hormone levels in postmenopausal breast cancer patients under long-term treatment with an aromatase inhibitor. Kanagawa AI Study Group. Gan To Kagaku Ryoho 26:2201–2208.PubMedGoogle Scholar
  39. 39.
    Holmberg L, Tamini R. (2005) Reducing cancer drug doses in obese patients: dogma disputed. Lancet 366:1056–1057.CrossRefPubMedGoogle Scholar
  40. 40.
    Gladieff L, Fumoleau P, Kerbrat P, Bonneterre J, Mayer F, Namer M, Monnier A, Goudier M-J, Luporsi E, Roche H. (2004) Which are the interactions between baseline body mass index, toxicity of chemotherapy and efficacy of adjuvant treatment? 9-year follow up Results of French Adjuvant Study Group (FASG) trials. Proceedings for ASCO 40th Annual Meeting, New Orleans, Louisiana, 2004.Google Scholar
  41. 41.
    Dawood S, Broglio K, Gonzalez-Angulo AM, et al. (2008) Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res 14:1718–1725.CrossRefPubMedGoogle Scholar
  42. 42.
    Vona-Davis L, Rose DP. (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14:189–206.CrossRefPubMedGoogle Scholar
  43. 43.
    Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92:720–729.CrossRefPubMedGoogle Scholar
  44. 44.
    Powis G, Reece P, Ahmann DL, Ingle JN. (1987) Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients. Cancer Chemother Pharmacol 20:219–222.CrossRefPubMedGoogle Scholar
  45. 45.
    Rodvold KA, Rushing DA, Tewksbury DA. (1988) Doxorubicin clearance in the obese. J Clin Oncol 6:1321–1327.PubMedGoogle Scholar
  46. 46.
    Williams G, Howell A, Jones M. (1988) The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast. Br J Cancer 58:631–634.PubMedGoogle Scholar
  47. 47.
    Artac M, Bozcuk H, Afacan B, Ozdogan M, Samur M. (2008) The impact of waist-to-hip ratio on clinical outcomes in metastatic breast cancer patients treated with aromatase inhibitors. Breast 17:418–422.CrossRefPubMedGoogle Scholar
  48. 48.
    Borugian MJ, Sheps SB, Kim-Sing C, et al. (2003) Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158:963–968.CrossRefPubMedGoogle Scholar
  49. 49.
    Abrahamson PE, Gammon MD, Lund MJ, et al. (2006) General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomark Prev 15:1871–1877.CrossRefGoogle Scholar
  50. 50.
    Goodwin PJ. (2008) Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions? J Clin Oncol 26:833–834.CrossRefPubMedGoogle Scholar
  51. 51.
    Eccles D, Gerty S, Simmonds P, Hammond V, Ennis S, Altman DG. (2007) Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol. BMC Cancer 7:160.CrossRefPubMedGoogle Scholar
  52. 52.
    Hede K. (2008) Doctors seek to prevent breast cancer recurrence by lowering insulin levels. J Natl Cancer Inst 100:530–532.CrossRefPubMedGoogle Scholar
  53. 53.
    Harvie MN, Malik R, Adams J, Frystyk J, Wale C, Howell A. (2004). The effects of weight loss and weight gain on IGF and IGF binding proteins in premenopausal women. J Nutr 134(12 suppl):(Conference abstract).Google Scholar
  54. 54.
    Irwin ML, McTiernan A, Bernstein L, et al. (2005) Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomark Prev 14:2881–2888.CrossRefGoogle Scholar
  55. 55.
    Werner RS, McCormick B, Petrek J, et al. (1991) Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 180:177–184.PubMedGoogle Scholar
  56. 56.
    Shaw C, Mortimer P, Judd PA. (2007) A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer 110:1868–1874.CrossRefPubMedGoogle Scholar
  57. 57.
    Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. J Am Med Assoc 285:885–892.CrossRefGoogle Scholar
  58. 58.
    Manjer J, Kaaks R, Riboli E, Berglund G. (2001) Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur J Cancer Prev 10:33–42.CrossRefPubMedGoogle Scholar
  59. 59.
    Schairer C, Mink PJ, Carroll L, Devesa SS. (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96:1311–1321.CrossRefPubMedGoogle Scholar
  60. 60.
    Barone BB, Yeh HC, Snyder CF, et al. (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. J Am Med Assoc 300:2754–2764.CrossRefGoogle Scholar
  61. 61.
    Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. (2005) Comorbidity and survival disparities among black and white patients with breast cancer. J Am Med Assoc 294:1765–1772.CrossRefGoogle Scholar
  62. 62.
    Hryniuk W. M, Banerji M. A, Heppner G, Du W, Severson R, Song EY. Adjuvant tamoxifen may be relatively ineffective in women with diabetes and breast cancer. Proc Am Soc Clin Oncol 20(36a):(Conference abstract).Google Scholar
  63. 63.
    de Waard F, Ramlau R, Mulders Y, de Vries T, van Waveren S. (1993) A feasibility study on weight reduction in obese postmenopausal breast cancer patients. Eur J Cancer Prev 2:233–238.CrossRefPubMedGoogle Scholar
  64. 64.
    Garrow JS, Summerbell CD. (1995) Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjects. Eur J Clin Nutr 49:1–10.PubMedGoogle Scholar
  65. 65.
    Goodwin P, Esplen MJ, Butler K, et al. (1998) Multidisciplinary weight management in locoregional breast cancer: Results of a phase II study. Breast Cancer Res Treat 48: 53–64.CrossRefPubMedGoogle Scholar
  66. 66.
    Loprinzi CL, Athmann LM, Kardinal CG, et al. (1996) Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy. Oncology 53:228–232.CrossRefPubMedGoogle Scholar
  67. 67.
    Markes M, Brockow T, Resch KL. (2006) Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev CD005001.Google Scholar
  68. 68.
    Ingram C, Courneya KS, Kingston D. (2006) The effects of exercise on body weight and composition in breast cancer survivors: an integrative systematic review. Oncol Nurs Forum 33:937–947.CrossRefPubMedGoogle Scholar
  69. 69.
    Demark-Wahnefried W, Case LD, Blackwell K, et al. (2008) Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer 8:70–79.CrossRefPubMedGoogle Scholar
  70. 70.
    Demark-Wahnefried W, Clipp EC, Morey MC, et al. (2006) Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from Project LEAD. J Clin Oncol 24:3465–3473.CrossRefPubMedGoogle Scholar
  71. 71.
    Pirozzo S, Summerbell C, Cameron C, Glasziou P. (2003) Should we recommend low-fat diets for obesity? Obes Rev 4:83–90.CrossRefPubMedGoogle Scholar
  72. 72.
    Pierce JP, Natarajan L, Caan B, Parker B. A, Greenberg ER, Flatt S. W, Rock CL. (18 July 2007) Influence of a diet very high in vegetables, fruit and fiber and low in fat on prognosis following treatment for breast cancer. J Am Med Assoc 298(3):289–298.CrossRefGoogle Scholar
  73. 73.
    Bingham SA, Luben R, Welch A, Wareham N, Khaw KT, Day N. (2003) Are imprecise methods obscuring a relation between fat and breast cancer? Lancet 362:212–214.CrossRefPubMedGoogle Scholar
  74. 74.
    Foster GD, Wyatt HR, Hill JO, et al. (2003) A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 348:2082–2090.CrossRefPubMedGoogle Scholar
  75. 75.
    Shai I, Schwarzfuchs D, Henkin Y, et al. (2008) Weight loss with a low-carbohydrate Mediterranean, or low-fat diet. N Engl J Med 359:229–241.CrossRefPubMedGoogle Scholar
  76. 76.
    Pelkman CL, Fishell VK, Maddox DH, Pearson TA, Mauger DT, Kris-Etherton PM. (2004) Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women. Am J Clin Nutr 79: 204–212.PubMedGoogle Scholar
  77. 77.
    Prakash P, Krinsky NI, Russell RM. (2000) Retinoids, carotenoids, and human breast cancer cell cultures: a review of differential effects. Nutr Rev 58:170–176.CrossRefPubMedGoogle Scholar
  78. 78.
    Fowke JH, Longcope C, Hebert JR. (2000) Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomark Prev 9:773–779.Google Scholar
  79. 79.
    Rolls BJ, Roe LS, Meengs JS. (2004) Salad and satiety: energy density and portion size of a first-course salad affect energy intake at lunch. J Am Diet Assoc 104:1570–1576.CrossRefPubMedGoogle Scholar
  80. 80.
    Hamajima N, Hirose K, Tajima K, et al. (2002) Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87:1234–1245.CrossRefPubMedGoogle Scholar
  81. 81.
    Rock CL, Demark-Wahnefried W. (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20:3302–3316.CrossRefPubMedGoogle Scholar
  82. 82.
    Lindstrom J, Peltonen M, Eriksson JG, et al. (2006) High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia 49:912–920.CrossRefPubMedGoogle Scholar
  83. 83.
    Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. (2005) Physical activity and survival after breast cancer diagnosis. J Am Med Assoc 293:2479–2486.CrossRefGoogle Scholar
  84. 84.
    Schwartz AL, Winters-Stone K, Gallucci B. (2007) Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 34:627–633.CrossRefPubMedGoogle Scholar
  85. 85.
    Saris WH, Blair SN van Baak MA, et al. (2003) How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev 4:101–114.CrossRefPubMedGoogle Scholar
  86. 86.
    Laws R. (2004) Current approaches to obesity management in UK Primary Care: the Counterweight Programme. J Hum Nutr Diet 17:183–190.CrossRefPubMedGoogle Scholar
  87. 87.
    Renjilian DA, Perri MG, Nezu AM, McKelvey WF, Shermer RL, Anton SD. (2001) Individual versus group therapy for obesity: effects of matching participants to their treatment preferences. J Consult Clin Psychol 69:717–721.CrossRefPubMedGoogle Scholar
  88. 88.
    Djuric Z, DiLaura NM, Jenkins I, et al. (2002) Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res 10:657–665.CrossRefPubMedGoogle Scholar
  89. 89.
    McBride CM, Clipp E, Peterson BL, Lipkus IM, Demark-Wahnefried W. (2000) Psychological impact of diagnosis and risk reduction among cancer survivors. Psychooncology 9:418–427.CrossRefPubMedGoogle Scholar
  90. 90.
    Straw S, Hopwood P, Mitchell H, Harvie M. (2006) The need for lifestyle advice amongst breast cancer patients – A patient and health care professional survey. Fourth Year Option Medicine Project, University of Manchester, Manchester.Google Scholar
  91. 91.
    Avenell A, Broom J, Brown TJ, et al. (2004) Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 8:iii–182.PubMedGoogle Scholar
  92. 92.
    Jebb SA, Siervo M, Murgatroyd PR, Evans S, Fruhbeck G, Prentice AM. (2007) Validity of the leg-to-leg bioimpedance to estimate changes in body fat during weight loss and regain in overweight women: a comparison with multi-compartment models. Int J Obes (Lond) 31:756–762.Google Scholar
  93. 93.
    Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. (2002) Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 75:683–688.PubMedGoogle Scholar
  94. 94.
    Alberti KG, Zimmet P, Shaw J. (2006) Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23:469–480.CrossRefPubMedGoogle Scholar
  95. 95.
    World Health Organisation (WHO), National Union of Teachers NUT & National Council on Disability NCD. (1997) Obesity: preventing and managing the global epidemic. Report of WHO Consultation on Obesity, Geneva Switzerland.Google Scholar
  96. 96.
    Reid DM, Doughty J, Eastell R, et al. (2008) Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. Cancer Treat Rev 34:S3–S18.CrossRefPubMedGoogle Scholar
  97. 97.
    Shapses SA, Riedt CS. (2006) Bone, body weight, and weight reduction: what are the concerns? J Nutr 136, 1453–1456.PubMedGoogle Scholar
  98. 98.
    Figueiredo MI, Cullen J, Hwang YT, Rowland JH, Mandelblatt JS. (2004) Breast cancer treatment in older women: does getting what you want improve your long-term body image and mental health? J Clin Oncol 22:4002–4009.CrossRefPubMedGoogle Scholar
  99. 99.
    Guthrie JR, Taffe JR, Lehert P, Burger HG, Dennerstein L. (2004) Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 11:315–322.CrossRefPubMedGoogle Scholar
  100. 100.
    Monnin S, Schiller MR, Sachs L, Smith AM. (1993) Nutritional concerns of women with breast cancer. J Cancer Educ 8:63–69.CrossRefPubMedGoogle Scholar
  101. 101.
    McInnes JA, Knobf MT. (2001) Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer. Oncol Nurs Forum 28:675–684.PubMedGoogle Scholar
  102. 102.
    Maciejewski ML, Patrick DL, Williamson DF. (2005) A structured review of randomized controlled trials of weight loss showed little improvement in health-related quality of life. J Clin Epidemiol 58:568–578.CrossRefPubMedGoogle Scholar
  103. 103.
    Salminen E, Bishop M, Poussa T, Drummond R, Salminen S. (2004) Dietary attitudes and changes as well as use of supplements and complementary therapies by Australian and Finnish women following the diagnosis of breast cancer. Eur J Clin Nutr 58:137–144.CrossRefPubMedGoogle Scholar
  104. 104.
    Demark-Wahnefried W, Morey MC, Clipp EC, et al. (2003) Leading the Way in Exercise and Diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors. Control Clin Trials 24:206–223.CrossRefPubMedGoogle Scholar
  105. 105.
    Daley AJ, Bowden SJ, Rea DW, Billingham L, Carmicheal AR. (2008) What advice are oncologists and surgeons in the United Kingdom giving to breast cancer patients about physical activity? Int J Behav Nutr Phys Act 5:46.CrossRefPubMedGoogle Scholar
  106. 106.
    Jones LW, Courneya KS, Peddle C, Mackey JR. (2005) Oncologists’ opinions towards recommending exercise to patients with cancer: a Canadian national survey. Supp Care Cancer 13:929–937.CrossRefGoogle Scholar
  107. 107.
    Kreuter MW, Chheda SG, Bull FC. (2000) How does physician advice influence patient behavior? Evidence for a priming effect. Arch Fam Med 9:426–433.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.University Hospital South ManchesterManchesterUK

Personalised recommendations